Medical Weight Loss for Bel Air, MD
Personalized weight-management consultations with telehealth access for eligible Maryland patients and in-person care at Green Relief Health’s Baltimore-area clinic.
- Medical history and medication review
- Eligibility and safety assessment
- FDA-approved options when appropriate
- Nutrition and activity planning
- Side-effect and progress monitoring
- Telehealth subject to clinical eligibility
Green Relief Health Does Not List a Physical Clinic in Bel Air
This page serves people searching for medical weight loss in Bel Air and surrounding Harford County communities. Telehealth may be available to eligible Maryland patients. The verified in-person location is 7690 Belair Road, Suite 1, Baltimore, MD 21236. Call before booking when you need to confirm visit type, laboratory arrangements, medication availability, or current pricing.
What Is Medical Weight Management?
Medical weight management combines clinical assessment, lifestyle support, and prescription treatment when appropriate. Medication is one possible tool; it does not replace nutrition, physical activity, sleep, behavioral support, or evaluation of conditions that affect weight.
Identify Health Factors
The initial assessment may review weight history, current medicines, eating pattern, activity, sleep, blood pressure, diabetes risk, reproductive plans, gastrointestinal symptoms, and previous treatment attempts.
Choose an Appropriate Plan
The plan may include nutrition goals, movement, behavioral strategies, laboratory testing when indicated, and an FDA-approved weight-management medicine if the expected benefit outweighs the risk.
Monitor and Adjust
Follow-up can assess weight trend, waist measurement, blood pressure, glucose when relevant, side effects, nutrition, hydration, lean-mass preservation, adherence, and whether treatment should continue or change.
How the Bel Air Medical Weight Loss Process Works
The exact sequence depends on health history, visit type, insurance or self-pay arrangements, and the treatment being considered.
Schedule and Complete Intake
Book online or call the office. Complete the requested medical, medication, allergy, pregnancy, and weight-history information before the visit.
Clinical Evaluation
A provider reviews eligibility, contraindications, current medicines, prior GLP-1 exposure, weight-related conditions, and alternatives. A prescription is not guaranteed.
Testing When Indicated
Laboratory testing is individualized. It may be used to assess diabetes, kidney or liver status, pregnancy risk, thyroid concerns, nutritional issues, or another condition suggested by history and examination.
Start the Plan
When medicine is prescribed, the patient receives product-specific instructions, dose-escalation guidance, storage and injection education when relevant, and a plan for common side effects.
Follow-Up
Follow-up timing is individualized rather than automatically every four weeks. Earlier review may be needed for significant symptoms, diabetes medicines, dose changes, pregnancy, or poor oral intake.
Long-Term Maintenance
Obesity is often chronic. Maintenance may involve continued medication, a lower or different regimen, nutrition and strength training, sleep treatment, or another strategy based on benefit, risk, affordability, and preference.
Weight Loss Medication Options
Brand name and indication matter. “Semaglutide” and “tirzepatide” describe active ingredients, but not every brand containing them is FDA-approved specifically for chronic weight management.
| Medication / Brand | FDA-Labeled Role | Important Clarification |
|---|---|---|
| Wegovy (semaglutide) | FDA-approved for long-term weight reduction in eligible adults and certain adolescents, with reduced-calorie eating and increased physical activity; it also has additional labeled indications in selected populations. | Do not combine with another semaglutide product or another GLP-1 receptor agonist unless a qualified prescriber specifically directs care consistent with current labeling. |
| Zepbound (tirzepatide) | FDA-approved for long-term weight reduction in eligible adults and for moderate-to-severe obstructive sleep apnea in adults with obesity, with lifestyle intervention. | Do not combine with another tirzepatide product or another GLP-1 receptor agonist. |
| Ozempic (semaglutide) | FDA-approved for type 2 diabetes and selected diabetes-related risk reduction—not specifically as a chronic weight-management brand. | Weight change can occur, but advertising it as an FDA-approved weight-loss drug is inaccurate. |
| Mounjaro (tirzepatide) | FDA-approved to improve glycemic control in adults and qualifying pediatric patients with type 2 diabetes—not specifically as a chronic weight-management brand. | Zepbound is the tirzepatide brand with the U.S. chronic weight-management indication. |
| Other prescription options | Several oral and injectable medicines may be considered depending on medical history, age, conditions, interactions, coverage, and patient preference. | A GLP-1 medicine is not the only evidence-based option and is not appropriate for every patient. |
Eligibility Is Based on More Than a Desire to Lose Weight
For many FDA-approved chronic weight-management medicines, adult eligibility commonly begins at a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition. A clinician still must determine whether a specific medicine is appropriate.
Factors That May Support an Evaluation
- BMI of 30 or greater
- BMI of 27 or greater with a weight-related condition
- High blood pressure, dyslipidemia, type 2 diabetes, sleep apnea, or another relevant condition
- Previous lifestyle attempts without durable results
- Willingness to make sustainable eating and activity changes
- Ability to attend monitoring and report side effects
Reasons Treatment May Be Avoided, Delayed, or Modified
- Pregnancy, planned pregnancy, or breastfeeding considerations
- Personal or family history of medullary thyroid carcinoma or MEN2 for Wegovy/Zepbound
- Severe gastroparesis or significant gastrointestinal symptoms
- Active eating disorder or unstable mental-health condition requiring specialized care
- Prior serious hypersensitivity to the medicine
- Inability to maintain fluids or nutrition
- Medication interactions or uncontrolled medical conditions
How Much Weight Can You Lose?
There is no guaranteed result. Average clinical-trial outcomes differ by medication, dose, duration, diabetes status, lifestyle program, adherence, and how missing data are analyzed. Individual results may be greater, smaller, or absent.
Clinically meaningful improvement is not limited to the scale. A program may also track waist circumference, blood pressure, glucose or A1C, lipids, sleep apnea symptoms, mobility, strength, medication needs, and quality of life.
Common Side Effects and Important Red Flags
Side effects depend on the medicine. The following examples focus on semaglutide and tirzepatide products and do not replace the current prescribing information.
Common Gastrointestinal Effects
Nausea, diarrhea, vomiting, constipation, abdominal discomfort, indigestion, reflux, belching, and reduced appetite can occur—particularly during dose escalation.
Nutrition and Hydration
Persistent symptoms can cause dehydration, kidney injury, weakness, and inadequate protein or nutrient intake. Contact the provider when fluids or food cannot be maintained.
Low Blood Sugar
Risk can increase when GLP-1–based treatment is used with insulin or a sulfonylurea. Diabetes medicines may require clinician-directed adjustment.
Gallbladder or Pancreas Symptoms
Severe persistent abdominal pain, pain radiating to the back, fever, jaundice, or repeated vomiting requires prompt medical assessment.
Pregnancy and Contraception
Weight-loss treatment is generally stopped when pregnancy is recognized. Tirzepatide can affect oral contraceptive absorption during initiation and dose escalation; discuss backup contraception.
Procedures and Anesthesia
Tell surgeons, anesthesiology teams, and endoscopy clinicians about GLP-1 treatment because delayed gastric emptying may increase aspiration risk.
Dr. Lauren Nawrocki, DNP, CRNP
Dr. Lauren Nawrocki provides medical weight-management consultations through Green Relief Health. The purpose of the visit is to evaluate the patient’s health history, goals, medication risks, and available treatment options—not to automatically prescribe a specific injection.
- Medical and medication-history review
- Individualized eligibility assessment
- Education about benefits, limitations, and risks
- Follow-up and dose review when treatment is prescribed
- Telehealth and in-person scheduling based on clinical needs
Credentials, licenses, certifications, and professional memberships should be confirmed through the relevant licensing or certifying organization when they are important to your decision.
How Much Does Medical Weight Loss Cost?
Current pricing was not stated in the supplied page code. Costs can include the initial evaluation, follow-up visits, laboratory testing, medication, supplies, prior-authorization work, and nutrition or coaching services.
Ask What Is Included
Confirm whether the quoted price covers consultation, labs, medication, needles or supplies, follow-up, messaging, and dose changes.
Insurance Varies
Coverage depends on the plan, diagnosis, medication, prior authorization, employer exclusions, and pharmacy benefit. Coverage is never guaranteed.
Brand vs Compounded
Do not compare price alone. FDA-approved branded products and compounded products have different regulatory review, sourcing, and quality considerations.
Medical Weight Loss Support Near Bel Air
Green Relief Health serves people in Bel Air, Forest Hill, Fallston, Abingdon, Edgewood, Aberdeen, and surrounding Maryland communities through telehealth when clinically appropriate. In-person care is provided at the Baltimore-area address below.
Telehealth can be useful for history review, medication education, progress checks, and selected follow-up visits. Some patients may still need in-person examination, blood-pressure checks, laboratory testing, pregnancy testing, urgent evaluation, or coordination with a primary-care or specialty clinician.
Telehealth availability depends on the patient’s physical location at the time of the visit, clinician licensure, medical complexity, technology, and current laws and practice policies.
Green Relief Health
In-person address:
7690 Belair Road, Suite 1
Baltimore, MD 21236
Phone: (410) 368-0420
Email: info@greenreliefmd.com
Website-listed hours:
Monday–Friday, 9:00 AM–5:00 PM
Green Relief Health Reviews
Reviews can describe patient experience but do not guarantee a medical result. Consider provider qualifications, safety process, pricing, follow-up access, and medication sourcing alongside ratings.

Medical Weight Loss in Bel Air, MD
The verified Green Relief Health in-person address is 7690 Belair Road, Suite 1, Baltimore, MD 21236. Bel Air and Harford County residents may use telehealth when eligible. Confirm visit type before scheduling.
Green Relief Health advertises telehealth access. Availability depends on the patient’s location, clinician licensure, medical history, treatment needs, and current practice requirements. Some testing or examination may need to occur in person.
Examples include Wegovy (semaglutide) and Zepbound (tirzepatide) for eligible patients. Ozempic and Mounjaro contain the same respective active ingredients but have diabetes indications rather than FDA approval specifically as chronic weight-management brands.
Many FDA-approved chronic weight-management medicines are indicated for adults with BMI 30 or greater, or BMI 27 or greater with at least one weight-related condition. Eligibility and medication choice require an individualized assessment.
No. A provider may recommend lifestyle treatment, testing, another medicine, coordination with another clinician, or no prescription when risks outweigh expected benefits.
No. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before marketing. They are not the same as FDA-approved generics.
Results vary. Starter doses focus on tolerability, while meaningful weight trends are usually judged over months. Do not compare an early response with a clinical trial result measured after a year or longer.
Follow-up may review weight trend, waist measurement, blood pressure, glucose, side effects, hydration, bowel symptoms, nutrition, activity, lean-mass preservation, adherence, dose, and whether treatment remains appropriate.
Possibly, but diabetes medicines can interact with weight-management treatment and may increase the risk of low blood sugar. Blood glucose and medication doses may need closer monitoring by the prescribing clinicians.
Weight-loss treatment is generally discontinued when pregnancy is recognized. Discuss planned pregnancy and contraception before treatment. Semaglutide and tirzepatide have different product-specific reproductive guidance.
Coverage varies by health plan, employer exclusions, diagnosis, medication, pharmacy benefit, and prior authorization. Ask both the clinic and insurer for an itemized estimate and coverage requirements.
Ask what the price includes, which medication and pharmacy are used, whether the product is FDA-approved or compounded, follow-up frequency, lab costs, insurance support, refund and cancellation rules, and how urgent side effects are handled.
Start with a Medical Evaluation
Bel Air and Harford County residents can discuss weight history, health conditions, medication options, costs, and a realistic long-term plan with Green Relief Health.


































